Physician profile
Leonid Mandel
NPI 1710902846
$17,525.87
in general payments reported to CMS, 2019-2025
57 companies · $2,175 in 2025
The $2,175 reported for 2025 was more than what 85% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,555 · 2020: $1,326 · 2021: $2,408 · 2022: $2,784 · 2023: $3,354 · 2024: $2,926 · 2025: $2,175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,439 · Consulting Fee: $15.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,439.01 |
| Consulting Fee | $15.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,878.91 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $1,149.64 | 2019-2025 | |
| Boston Scientific Corporation | $1,134.92 | 2019-2025 | Watchman Flx, Watchman Access System, Watchdog |
| Edwards Lifesciences Corporation | $895.68 | 2019-2025 | Sapien 3 Ultra Resilia, Pascal |
| Janssen Pharmaceuticals, INC | $863.52 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $815.86 | 2019-2025 | Jardiance |
| Sanofi-Aventis U.S. LLC | $811.92 | 2019-2024 | |
| Amarin Pharma, INC. | $673.56 | 2019-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $672.99 | 2019-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $663.30 | 2021-2025 | Verquvo, Capvaxive |
| Novo Nordisk INC | $627.30 | 2022-2025 | Wegovy, Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $608.03 | 2019-2025 | Farxiga, Wainua |
| Baxter Healthcare | $579.08 | 2023-2025 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| Cardiovascular Systems INC. | $576.64 | 2019-2022 | |
| Alnylam Pharmaceuticals INC. | $570.50 | 2020-2025 | Onpattro, Amvuttra |
Show all 57 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $524.07 | 2019-2025 | |
| Arbor Pharmaceuticals, INC. | $504.64 | 2019-2021 | |
| Scpharmaceuticals INC. | $362.46 | 2023-2025 | |
| Esperion Therapeutics, INC. | $341.27 | 2021-2025 | Nexletol |
| Kowa Pharmaceuticals America, INC. | $288.55 | 2019-2024 | Livalo |
| Irhythm Technologies, INC. | $275.15 | 2021-2024 | Zio Xt Patch, Zio Monitor |
| Medtronic Vascular, INC. | $239.48 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $223.12 | 2019-2024 | Camzyos |
| Kestra Medical Technology Services, INC. | $209.98 | 2022-2025 | Assure Wcd |
| Regeneron Healthcare Solutions, INC. | $180.13 | 2019-2023 | Evkeeza |
| Cvrx, INC. | $178.85 | 2024-2025 | Barostim Neo System |
| Abbott Laboratories | $157.70 | 2020-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Abiomed | $154.24 | 2019-2021 | |
| Kiniksa Pharmaceuticals, LTD. | $117.09 | 2022-2023 | Arcalyst |
| Heartflow, INC. | $106.38 | 2022-2025 | Ffrct |
| Kiniksa Pharmaceuticals International, Plc | $98.79 | 2024 | Arcalyst |
| Biosense Webster, INC. | $83.42 | 2019-2023 | Carto 3 |
| Lilly USA, LLC | $80.91 | 2024-2025 | Zepbound, Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $79.84 | 2021-2025 | |
| Bridgebio Pharma, INC. | $73.58 | 2025 | Attruby |
| Impulse Dynamics (USA) INC. | $70.74 | 2022-2024 | Optimizer |
| Cardiva Medical, INC. | $69.14 | 2021 | |
| Philips North America LLC | $65.76 | 2024-2025 | (5044) Mcot, Extended Holter |
| Lundbeck LLC | $62.65 | 2019-2021 | |
| Medtronic, INC. | $57.11 | 2021-2024 | Corevalve Evolut R |
| Lexicon Pharmaceuticals, INC. | $52.45 | 2023-2024 | Inpefa |
| Genzyme Corporation | $52.04 | 2023-2024 | |
| Althera Pharmaceuticals LLC | $43.36 | 2022 | |
| Atricure, INC. | $40.41 | 2021-2024 | |
| Inspire Medical Systems, INC. | $23.01 | 2023 | Inspire |
| Medicomp INC | $19.13 | 2019 | |
| Acarix USA INC. | $18.90 | 2024 | Cadscor System |
| Ionis Pharmaceuticals, INC. | $16.38 | 2025 | Tryngolza |
| Daiichi Sankyo INC. | $16.24 | 2019 | |
| La Jolla Pharmaceutical Company | $15.45 | 2024 | Giapreza |
| Glaxosmithkline, LLC. | $15.45 | 2025 | Arexvy, Shingrix |
| Azurity Pharmaceuticals, INC. | $15.27 | 2024 | Edarbi |
| Medicure Pharma INC. | $15.00 | 2021 | |
| Bardy Diagnostics, INC. | $15.00 | 2021 | |
| Tactile Systems Technology INC | $14.20 | 2020 | |
| Chiesi USA, INC. | $13.35 | 2022 | |
| Amryt Pharma Holdings LTD | $13.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leonid Mandel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.